CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,786,223 | +261.7% | 656,353 | +165.7% | 0.00% | – |
Q2 2023 | $2,705,373 | -77.8% | 247,066 | -82.3% | 0.00% | -100.0% |
Q1 2023 | $12,195,993 | +276.5% | 1,398,623 | +170.7% | 0.00% | +100.0% |
Q4 2022 | $3,239,508 | +389.4% | 516,668 | +173.1% | 0.00% | – |
Q3 2022 | $662,000 | +120.7% | 189,184 | +85.8% | 0.00% | – |
Q2 2022 | $300,000 | -53.2% | 101,800 | -50.6% | 0.00% | – |
Q1 2022 | $641,000 | -62.3% | 206,018 | -59.0% | 0.00% | – |
Q4 2021 | $1,700,000 | +27.7% | 502,690 | +37.9% | 0.00% | – |
Q3 2021 | $1,331,000 | -41.3% | 364,600 | -29.9% | 0.00% | – |
Q2 2021 | $2,268,000 | +4.8% | 520,233 | +9.1% | 0.00% | – |
Q1 2021 | $2,165,000 | -61.8% | 477,029 | -51.7% | 0.00% | – |
Q4 2020 | $5,664,000 | +77.6% | 987,046 | +124.0% | 0.00% | – |
Q3 2020 | $3,190,000 | +21.4% | 440,600 | -41.5% | 0.00% | – |
Q2 2020 | $2,627,000 | +1905.3% | 752,577 | +748.3% | 0.00% | – |
Q1 2020 | $131,000 | -49.4% | 88,715 | -32.9% | 0.00% | – |
Q4 2019 | $259,000 | -91.4% | 132,195 | -77.5% | 0.00% | -100.0% |
Q3 2019 | $3,011,000 | -71.9% | 588,077 | -60.7% | 0.00% | 0.0% |
Q2 2019 | $10,706,000 | +583.2% | 1,495,184 | +1167.1% | 0.00% | – |
Q1 2019 | $1,567,000 | +280.3% | 118,000 | +125.6% | 0.00% | – |
Q4 2018 | $412,000 | -47.8% | 52,300 | -26.5% | 0.00% | – |
Q3 2018 | $789,000 | -24.4% | 71,200 | -8.5% | 0.00% | – |
Q2 2018 | $1,044,000 | -63.3% | 77,800 | -64.5% | 0.00% | -100.0% |
Q1 2018 | $2,848,000 | +361.6% | 219,167 | +227.1% | 0.00% | – |
Q4 2017 | $617,000 | +8.8% | 67,000 | -4.8% | 0.00% | – |
Q3 2017 | $567,000 | +636.4% | 70,390 | +427.3% | 0.00% | – |
Q2 2017 | $77,000 | +79.1% | 13,349 | -47.5% | 0.00% | – |
Q4 2015 | $43,000 | -88.5% | 25,405 | -53.0% | 0.00% | – |
Q1 2015 | $374,000 | – | 54,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |